Zobrazeno 1 - 10
of 204
pro vyhledávání: '"UK variant B.1.1.7"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Microbiology Spectrum, Vol 9, Iss 1 (2021)
ABSTRACT Monitoring and strategic response to variants in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represent a considerable challenge in the current pandemic and for future viral outbreaks. Mutations/deletions of the virion’s pr
Externí odkaz:
https://doaj.org/article/f2d56f972265431d9f0e200c399e8cb4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2021 Apr 02. Date of Electronic Publication: 2021 Apr 02.
Publikováno v:
Microbiology Spectrum
Microbiology Spectrum, Vol 9, Iss 1 (2021)
Microbiology Spectrum, Vol 9, Iss 1 (2021)
Monitoring and strategic response to variants in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represent a considerable challenge in the current pandemic and for future viral outbreaks. Mutations/deletions of the virion’s prefusion S
Autor:
Jonathan B. Gubbay, Lee W. Goneau, Kevin A. Brown, Jessica Hopkins, Samir N. Patel, Sarah A Buchan, Nick Daneman
A novel variant of SARS-CoV-2, B.1.1.7, originally discovered in the United Kingdom (UK), is rapidly overtaking other strains around the globe. In certain assays, absence of detection of the S-gene target, also known as S-gene target failure (SGTF) c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9ad8ac91f0f2543eaf96c8cc783f838
https://doi.org/10.1101/2021.02.09.21251225
https://doi.org/10.1101/2021.02.09.21251225
Publikováno v:
bioRxiv
Monitoring and strategic response to variants in SARS-CoV-2 represents a considerable challenge in the current pandemic, as well as potentially future viral outbreaks of similar magnitude. In particular mutations and deletions involving the virion’
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a5847a09c2b72f43054998383279b3c
https://europepmc.org/articles/PMC7885917/
https://europepmc.org/articles/PMC7885917/
Autor:
Alessandro Grottesi, Nico Sanna, Ingrid Guarnetti Prandi, Carmen Cerchia, Nabil Abid, Stefano Borocci, Giovanni Chillemi, Andrea R. Beccari, Carmine Talarico
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 5464, p 5464 (2021)
Volume 22
Issue 11
International Journal of Molecular Sciences, Vol 22, Iss 5464, p 5464 (2021)
Volume 22
Issue 11
The COVID-19 pandemic is caused by SARS-CoV-2. Currently, most of the research efforts towards the development of vaccines and antibodies against SARS-CoV-2 were mainly focused on the spike (S) protein, which mediates virus entry into the host cell b
Publikováno v:
EMBO Molecular Medicine, Vol 13, Iss 6, Pp 1-35 (2021)
Abstract Scientists and the public were alarmed at the first large viral variant of SARS‐CoV‐2 reported in December 2020. We have followed the time course of emerging viral mutants and variants during the SARS‐CoV‐2 pandemic in ten countries
Externí odkaz:
https://doaj.org/article/f9551a7d9c6d4f3db01b7c9a810f98a7
Publikováno v:
EMBO molecular medicine, vol 13, iss 6
Scientists and the public were alarmed at the first large viral variant of SARS-CoV-2 reported in December 2020. We have followed the time course of emerging viral mutants and variants during the SARS-CoV-2 pandemic in ten countries on four continent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::16bfaaf6f1279e2a0235462c0dee844d
https://escholarship.org/uc/item/01g392kt
https://escholarship.org/uc/item/01g392kt